Learn about colorectal cancer, its risk factors, symptoms, and the latest treatment options. Early detection through ...

Merck & Co.’s said a late-stage trial of its blockbuster cancer drug Keytruda in combination with favezelimab failed to meet ...

Over the past three decades, rates of colon cancer among young people have been steadily rising even as diagnoses among older ...

Researchers Chart a Course for Understanding, Preventing, and Treating Young-Onset Colorectal Cancer Mar. 16, 2023 — Researchers outline the complexities of young-onset colorectal cancer and the ...

Takeda (TSE:4502/NYSE:TAK) today announced that it has received approval from the Japanese Ministry of Health, Labour and ...

Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial ...

RFS is worse among individuals with synchronous colorectal liver metastases who receive a liver-first approach.

Medical professionals agree that undergoing a colonoscopy is key to catching colorectal cancer in its earliest and most treatable stages. Many younger people with colorectal cancer are ...

After facing colorectal cancer for nearly eight years, Mandy Wilk got a double-lung transplant in June at Northwestern. She ...

Colorectal cancer (CRC) stands as the second most common cause of cancer-related mortality globally and p53, a widely recognized tumor suppressor, contributes to the development of CRC.

A new, comprehensive study has uncovered critical insights into the genetic makeup of colorectal cancer (CRC), providing a ...

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, ...